ANI Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Highlights Operational Strength Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending KURA Q1 2026 Earnings WiderThanExpected Loss Amid Clinical Progress Veris Residential Inc Q4 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress WHLRL Q2 2024 Earnings Bondholder EPS Surprises Revenue Unreported REZI Q1 2026 Earnings Strong EPS Beat Amidst Mixed Market Reaction